Search

Author/Creator Tong, Gary

1. A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ‐secretase inhibitor avagacestat. (14th December 2012)

Authors:
Tong, Gary; Wang, Jun‐Sheng; Sverdlov, Oleksandr; Huang, Shu‐Pang; Slemmon, Randy; Croop, Robert; Castaneda, Lorna; Gu, Huidong; Wong, Oi; Li, Hewei; Berman, Robert M.; Smith, Christina; Albright, Charles F.; Dockens, Randy
Journal:
British journal of clinical pharmacology
Issue:
Volume 75:Number 1(2013:Jan.)
Page Start:
136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ‐secretase inhibitor avagacestat. (14th December 2012)

Authors:
Tong, Gary; Wang, Jun‐Sheng; Sverdlov, Oleksandr; Huang, Shu‐Pang; Slemmon, Randy; Croop, Robert; Castaneda, Lorna; Gu, Huidong; Wong, Oi; Li, Hewei; Berman, Robert M.; Smith, Christina; Albright, Charles F.; Dockens, Randy
Journal:
British journal of clinical pharmacology
Issue:
Volume 75:Number 1(2013:Jan.)
Page Start:
136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development. Issue 2 (8th October 2012)

Authors:
Boxer, Adam L.; Gold, Michael; Huey, Edward; Gao, Fen‐Biao; Burton, Edward A.; Chow, Tiffany; Kao, Aimee; Leavitt, Blair R.; Lamb, Bruce; Grether, Megan; Knopman, David; Cairns, Nigel J.; Mackenzie, Ian R.; Mitic, Laura; Roberson, Erik D.; Van Kammen, Daniel; Cantillon, Marc; Zahs, Kathleen; Sall...
Journal:
Alzheimer's & dementia
Issue:
Volume 9:Issue 2(2013)
Page Start:
176
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier). Issue 2 (12th October 2012)

Authors:
Boxer, Adam L.; Gold, Michael; Huey, Edward; Hu, William T.; Rosen, Howard; Kramer, Joel; Gao, Fen‐Biao; Burton, Edward A.; Chow, Tiffany; Kao, Aimee; Leavitt, Blair R.; Lamb, Bruce; Grether, Megan; Knopman, David; Cairns, Nigel J.; Mackenzie, Ian R.; Mitic, Laura; Roberson, Erik D.; Van Kammen, ...
Journal:
Alzheimer's & dementia
Issue:
Volume 9:Issue 2(2013)
Page Start:
189
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable. Issue 4 (1st April 2018)

Authors:
Knopman, David S.; Haeberlein, Samantha Budd; Carrillo, Maria C.; Hendrix, James A.; Kerchner, Geoff; Margolin, Richard; Maruff, Paul; Miller, David S.; Tong, Gary; Tome, Maria B.; Murray, Melissa E.; Nelson, Peter T.; Sano, Mary; Mattsson, Niklas; Sultzer, David L.; Montine, Thomas J.; Jack, Cli...
Journal:
Alzheimer's & dementia
Issue:
Volume 14:Issue 4(2018)
Page Start:
563
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗